View More Recent Stories

Dec 14, 2023 07:00AM TriSalus Life Sciences (TLSI) Announces CMS Reimbursement for the TriNav Infusion System via Assignment of a New Technology Healthcare Common Procedure Coding System Code
Dec 14, 2023 07:00AM TriSalus Life Sciences Announces CMS Reimbursement for the TriNavĀ® Infusion System via Assignment of a New Technology Healthcare Common Procedure Coding System (HCPCS) Code
Nov 14, 2023 08:00AM TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 7, 2023 04:05PM TriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference Call
Nov 4, 2023 02:25PM Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications
Nov 3, 2023 12:00PM TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 25, 2023 09:05AM TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Sep 6, 2023 07:00AM TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics
Aug 10, 2023 04:05PM TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
View More Recent Stories